Literature DB >> 18833074

308 nm monochromatic excimer light in dermatology: personal experience and review of the literature.

L Mavilia1, M Mori, R Rossi, P Campolmi, A Puglisi Guerra, T Lotti.   

Abstract

RESULTS: For over five years, we have been using a new ultraviolet B ray source, a Xenon-Chloride lamp emitting non-coherent, monochromatic 308-nm light that represents the natural evolution of the excimer laser. A source of monochromatic excimer light (MEL) produces 50 mW/cm(2) power density at a distance of 15 cm from the source and has a maximum irradiating area of 504 cm(2), this feature representing the greatest therapeutic advantage offered by 308 nm sources. On the other hand, the benefits offered by the MEL compared to traditional phototherapies are essentially correlated to the fact that there is no need to administer oral psoralens (PUVA therapy) and that sessions need to be repeated only every 7-15 days, an important condition for the improvement of the patient's quality of life (since at least 2-3 weekly sessions are required with the traditional UVB therapy). Using MEL, UV B light can be applied on the entire body, with partial subintrant skin irradiations, or on one or just a few individual patches, taking care to accurately protect the healthy surrounding skin and allowing for a phototherapy exclusively targeted onto the lesion to be treated. Clinical indications and the reasons for choosing MEL for the treatment of photosensitive skin disorders are virtually identical to those stated for PUVA therapy or narrowband UV B light. Due to the absence of photosensitizing substances and drug-induced toxicity, patients who work in the open air, pregnant women and patients suffering from liver or kidney failure can also be treated. Furthermore, the short time required for sessions, the duration of cycles and the selective exposure of the skin areas to be treated undoubtedly represent significant benefits for patients in terms of safety and efficacy. In addition to psoriasis, the use of MEL can also be extended to other pathologies such as vitiligo, alopecia areata, atopic dermatitis and patch-stage IA mycosis fungoides with encouraging

Entities:  

Mesh:

Year:  2008        PMID: 18833074

Source DB:  PubMed          Journal:  G Ital Dermatol Venereol        ISSN: 0392-0488            Impact factor:   2.011


  6 in total

Review 1.  308nm excimer laser in dermatology.

Authors:  Shadi Mehraban; Amir Feily
Journal:  J Lasers Med Sci       Date:  2014

2.  [Targeted UVB-308 nm (NUVB) therapy with excimer laser in the treatment of atopic dermatitis and other inflammatory dermatoses].

Authors:  I Wollenschläger; J Hermann; H M Ockenfels
Journal:  Hautarzt       Date:  2009-11       Impact factor: 0.751

3.  Pustular Palmoplantar Psoriasis Successfully Treated with Nb-UVB Monochromatic Excimer Light: A Case-Report.

Authors:  Serena Gianfaldoni; Georgi Tchernev; Uwe Wollina; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2017-07-19

4.  Excimer laser for psoriasis treatment: A case report and short review.

Authors:  Valeriu Ardeleanu; Diana Sabina Radaschin; Alin Laurentiu Tatu
Journal:  Exp Ther Med       Date:  2020-02-14       Impact factor: 2.447

5.  XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia.

Authors:  Ecem Esencan; Simge Yuksel; Yusuf Berk Tosun; Alexander Robinot; Ihsan Solaroglu; John H Zhang
Journal:  Med Gas Res       Date:  2013-02-01

6.  Efficacy of 308-nm Monochromatic Excimer Light in the Management of Halo Nevi: An Open-Label, Pilot Study.

Authors:  Swapnil D Shah; Amit Shah; Bhalachandra Ankad; Sharad Mutalik
Journal:  J Cutan Aesthet Surg       Date:  2019 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.